Get started
Author

Mathieu Ferrari

Observed names: M Ferrari, M. Ferrari
ORCID: 0000-0001-8535-7348
Observed ORCID: 0000-0001-8535-7348
OpenAlex ID: A5089556001
Enhanced CAR T cell expansion and prolonged persistence in pediatric patients with ALL treated with a low-affinity CD19 CAR
2019 · Sara Ghorashian, Anne Marijn Kramer, et al. · Nature Medicine · 655
PDF
CAR T cells with dual targeting of CD19 and CD22 in pediatric and young adult patients with relapsed or refractory B cell acute lymphoblastic leukemia: a phase 1 trial
2021 · Shaun Cordoba, Shimobi Onuoha, et al. · Nature Medicine · 302
PDF
Trojan horses and guided missiles: targeted therapies in the war on arthritis
2015 · Mathieu Ferrari, Shimobi C. Onuoha, et al. · Nature Reviews Rheumatology · 69
Dual T-cell constant β chain (TRBC)1 and TRBC2 staining for the identification of T-cell neoplasms by flow cytometry
2024 · Pedro Horna, Matthew J. Weybright, et al. · Blood Cancer Journal · 68
PDF
TRBC1-CAR T cell therapy in peripheral T cell lymphoma: a phase 1/2 trial
2024 · Kate Cwynarski, Gloria Iacoboni, et al. · Nature Medicine · 52
Limited efficacy of APRIL CAR in patients with multiple myeloma indicate challenges in the use of natural ligands for CAR T-cell therapy
2023 · Lydia Lee, Wen Chean Lim, et al. · Journal for ImmunoTherapy of Cancer · 48
PDF
Dual targeting of CD19 and CD22 against B-ALL using a novel high-sensitivity aCD22 CAR
2023 · Evangelia Kokalaki, Biao Ma, et al. · Molecular Therapy · 44
PDF
Characterization of a Novel ACE2-Based Therapeutic with Enhanced Rather than Reduced Activity against SARS-CoV-2 Variants
2021 · Mathieu Ferrari, Leila Mekkaoui, et al. · Journal of Virology · 38
PDF
IκB Kinase ε Targets Interferon Regulatory Factor 1 in Activated T Lymphocytes
2014 · Marco Sgarbanti, Giulia Marsili, et al. · Molecular and Cellular Biology · 35
Structure-guided engineering of immunotherapies targeting TRBC1 and TRBC2 in T cell malignancies
2024 · Mathieu Ferrari, Matteo Righi, et al. · Nature Communications · 26
PDF
Combining phage display with SMRTbell next-generation sequencing for the rapid discovery of functional scFv fragments
2020 · Francesco Nannini, Lenart Senicar, et al. · mAbs · 24
Rational Design of Antirheumatic Prodrugs Specific for Sites of Inflammation
2015 · Shimobi C. Onuoha, Mathieu Ferrari, et al. · Arthritis & Rheumatology · 21
PDF
Novel Bispecific Antibody for Synovial-Specific Target Delivery of Anti-TNF Therapy in Rheumatoid Arthritis
2021 · Mathieu Ferrari, Shimobi C. Onuoha, et al. · Frontiers in Immunology · 17
PDF
A tetrameric ACE2 protein broadly neutralizes SARS-CoV-2 spike variants of concern with elevated potency
2021 · Adam Leach, F. Tudor Ilca, et al. · Antiviral Research · 16
PDF
Going with the flow: harnessing the power of the vasculature for targeted therapy in rheumatoid arthritis
2015 · Mathieu Ferrari, Shimobi C. Onuoha, et al. · Drug Discovery Today · 13
Development of a novel recombinant biotherapeutic with applications in targeted therapy of human arthritis
2011 · Panagiotis Kamperidis, Tahereh Kamalati, et al. · Arthritis & Rheumatism · 13
Structure Guided Engineering of Highly Specific Chimeric Antigen Receptors for the Treatment of T Cell Lymphomas
2018 · Shimobi Onuoha, Mathieu Ferrari, et al. · Blood · 10
Exploration of T cell immune responses by expression of a dominant-negative SHP1 and SHP2
2023 · Julia Taylor, Anna Bulek, et al. · Frontiers in Immunology · 9
PDF
Designer Small-Molecule Control System Based on Minocycline-Induced Disruption of Protein–Protein Interaction
2024 · Ram Jha, Alexander Kinna, et al. · ACS Chemical Biology · 8
Anti-CD21 Chimeric Antigen Receptor (CAR)-T Cells for T Cell Acute Lymphoblastic Leukaemia (T-ALL)
2021 · Nicola C Maciocia, Amy Burley, et al. · Blood · 7
A primer set for the rapid isolation of scFv fragments against cell surface antigens from immunised rats
2020 · Francesco Nannini, Farhaan Parekh, et al. · Scientific Reports · 7
PDF
Abstract 2183: Targeting TRBC1 and 2 for the treatment of T cell lymphomas
2020 · Mathieu Ferrari, Vania Baldan, et al. · Cancer Research · 6
CAR T cell therapy selectively depletes disease-driving mutant calreticulin cells in xenotransplants and human organoid models of myelofibrosis
2026 · Alexandros Rampotas, Zoë C. Wong, et al. · Science Translational Medicine · 5
Optimised Method for the Production and Titration of Lentiviral Vectors Pseudotyped with the SARS-CoV-2 Spike
2021 · Leila Mekkaoui, Emma Bentley, et al. · BIO-PROTOCOL · 4
Dual targeting of CD19 and CD22 against B-ALL using a novel high-sensitivity aCD22 CAR
2023 · Evangelia Kokalaki, Biao Ma, et al. · Molecular Therapy · 2
Works count: 39
Citation count: 1,511
H-index: 14
I10-index: 17
Year
Topic
Type